Soichiro Shimizu

2.1k total citations
86 papers, 1.4k citations indexed

About

Soichiro Shimizu is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, Soichiro Shimizu has authored 86 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Psychiatry and Mental health, 42 papers in Physiology and 27 papers in Neurology. Recurrent topics in Soichiro Shimizu's work include Dementia and Cognitive Impairment Research (50 papers), Alzheimer's disease research and treatments (33 papers) and Neurological Disease Mechanisms and Treatments (20 papers). Soichiro Shimizu is often cited by papers focused on Dementia and Cognitive Impairment Research (50 papers), Alzheimer's disease research and treatments (33 papers) and Neurological Disease Mechanisms and Treatments (20 papers). Soichiro Shimizu collaborates with scholars based in Japan and United States. Soichiro Shimizu's co-authors include Haruo Hanyu, Hidekazu Kanetaka, Toshihiko Iwamoto, Kentaro Ishii, T. Sato, Kiyoshi Koizumi, Kimihiko Abe, Hirofumi Sakurai, Daisuke Hirose and Hirokuni Hatanaka and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Soichiro Shimizu

77 papers receiving 1.4k citations

Peers

Countries citing papers authored by Soichiro Shimizu

Since Specialization

Citations

This map shows the geographic impact of Soichiro Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Shimizu more than expected).

Fields of papers citing papers by Soichiro Shimizu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Shimizu. The network helps show where Soichiro Shimizu may publish in the future.

Co-authorship network of co-authors of Soichiro Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Shimizu. A scholar is included among the top collaborators of Soichiro Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Shimizu. Soichiro Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer’s Disease 2025 ·Biomolecules ·(unknown), Tamao Tsukie, (unknown), Kiyoshi Onda, Yasuo Miyagi, (unknown), Soichiro Shimizu, Akinori Miyashita, Osamu Onodera, Takeshi Ikeuchi, Kensaku Kasuga	0
2	Detection of BRAF V600E mutation in radiological Langerhans cell histiocytosis-associated neurodegenerative disease using droplet digital PCR analysis 2023 ·International Journal of Hematology ·Soichiro Shimizu, Kenichi Sakamoto, Ko Kudo, Akira Morimoto, Yoko Shioda	1
3	Longitudinal patterns of Alzheimer's disease subtypes: A follow‐up magnetic resonance imaging and single‐photon emission computed tomography study 2023 ·Geriatrics and gerontology international ·Haruo Hanyu, (unknown), (unknown), Sadayoshi Watanabe, T. Sato, Hidekazu Kanetaka, Soichiro Shimizu, Kentaro Ishii	3
4	The clinical application of optimized AT(N) classification in Alzheimer’s clinical syndrome (ACS) and non-ACS conditions 2023 ·Neurobiology of Aging ·Kensaku Kasuga, Tamao Tsukie, Masataka Kikuchi, Takayoshi Tokutake, (unknown), Soichiro Shimizu, Hiroshi Yoshizawa, (unknown), (unknown), Hiroshi Mori, Yasuaki Arakawa, Kiyoshi Onda, Akinori Miyashita, Osamu Onodera, Takeshi Iwatsubo, Takeshi Ikeuchi	15
5	Association between longitudinal changes in striatal dopamine transporter uptake and clinical features of dementia with Lewy bodies 2023 ·Psychogeriatrics ·Ryō Yamamoto, (unknown), (unknown), Hikaru Kato, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mana Yoshimura, Kazuhiro Saito, Soichiro Shimizu, T. Sato	2
6	Association of regional white matter hyperintensity volumes with cognitive dysfunction and vascular risk factors in patients with amnestic mild cognitive impairment 2021 ·Geriatrics and gerontology international ·Kentaro Ishii, Fumio Yamashita, (unknown), (unknown), (unknown), Raita Fukasawa, T. Sato, Hidekazu Kanetaka, Takahiko Umahara, Hirofumi Sakurai, Haruo Hanyu, Soichiro Shimizu	5
7	Essential autophagic protein Beclin 1 localizes to atherosclerotic lesions of human carotid and major intracranial arteries 2020 ·Journal of the Neurological Sciences ·Takahiko Umahara, Toshiki Uchihara, Kentaro Ishii, Soichiro Shimizu, Takao Hashimoto, Michihiro Kohno, Haruo Hanyu	9
8	Ambulatory glucose profile in diabetes‐related dementia 2019 ·Geriatrics and gerontology international ·Yusuke Ogawa, Soichiro Shimizu, (unknown), Yoshitsugu Kaneko, (unknown), Haruo Hanyu	3
9	Effect of phytohemagglutinin (PHA) on nuclear transfer pig embryos in vitro 2019 ·Journal of Mammalian Ova Research ·(unknown), Soichiro Shimizu, Masaki Hata, (unknown), (unknown), Yōkō Kato	1
10	Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment 2019 ·Geriatrics and gerontology international ·Kentaro Ishii, Fumio Yamashita, (unknown), (unknown), Raita Fukasawa, T. Sato, (unknown), Soichiro Shimizu, Hidekazu Kanetaka, Takahiko Umahara, Hirofumi Sakurai, Haruo Hanyu	9
11	Role of Neuroimaging as a Biomarker for Neurodegenerative Diseases 2018 ·Frontiers in Neurology ·Soichiro Shimizu, Daisuke Hirose, Hirokuni Hatanaka, (unknown), Yoshitsugu Kaneko, Yusuke Ogawa, Hirofumi Sakurai, Haruo Hanyu	23
12	Comparison of diagnostic utility of semi-quantitative analysis for DAT-SPECT for distinguishing DLB from AD 2017 ·Journal of the Neurological Sciences ·Soichiro Shimizu, (unknown), Daisuke Hirose, Hidekazu Kanetaka, Kentaro Ishii, Hirokuni Hatanaka, (unknown), Yoshitsugu Kaneko, Yusuke Ogawa, (unknown), Takahiko Umahara, Hirofumi Sakurai, Haruo Hanyu	11
13	Association Between ApoE Phenotypes and Telomere Erosion in Alzheimer’s Disease 2011 ·The Journals of Gerontology Series A ·Yusuke Takata, (unknown), Haruo Hanyu, Shunichi Koyama, Soichiro Shimizu, Takahiko Umahara, Hirofumi Sakurai, Toshihiko Iwamoto, Kazuma Ohyashiki, Junko H. Ohyashiki	44
14	Prediction of the development of Alzheimer disease in patients with mild cognitive impairment 2010 ·Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·Kazumasa Kume, Haruo Hanyu, T. Sato, Kentaro Ishii, Hidekazu Kanetaka, Soichiro Shimizu, Hirofumi Sakurai, Toshihiko Iwamoto	2
15	Favourable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment 2007 ·Nuclear Medicine Communications ·Haruo Hanyu, Kentaro Ishii, Soichiro Shimizu, Toshihiko Iwamoto, Kiyoshi Koizumi, Kimihiko Abe	30
16	SPECT Follow-Up Study of Cerebral Blood Flow Changes During Donepezil Therapy in Patients with Alzheimer's Disease 2006 ·Journal of Neuroimaging ·Soichiro Shimizu, Haruo Hanyu, Toshihiko Iwamoto, Kiyoshi Koizumi, Kimihiko Abe	43
17	The Role of <sup>123</sup>I-Metaiodobenzylguanidine Myocardial Scintigraphy in the Diagnosis of Lewy Body Disease in Patients with Dementia in a Memory Clinic 2006 ·Dementia and Geriatric Cognitive Disorders ·Haruo Hanyu, Soichiro Shimizu, Kentaro Ishii, Hirofumi Sakurai, Toshihiko Iwamoto, Taishiro Chikamori, Satoshi Hida, Akira Yamashina, Kiyoshi Koizumi, Kimihiko Abe	41
18	Differentiation of Dementia with Lewy Bodies from Alzheimer’s Disease Using Brain SPECT 2005 ·Dementia and Geriatric Cognitive Disorders ·Soichiro Shimizu, Haruo Hanyu, Hidekazu Kanetaka, Toshihiko Iwamoto, Kiyoshi Koizumi, Kimihiko Abe	60
19	Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease 2005 ·Neuroscience Letters ·Haruo Hanyu, Soichiro Shimizu, Yuriko Tanaka, Hidekazu Kanetaka, Toshihiko Iwamoto, Kimihiko Abe	19
20	Cerebral microbleeds in Binswanger's disease: a gradient-echo T2-weighted magnetic resonance imaging study 2003 ·Neuroscience Letters* ·Haruo Hanyu, Yuriko Tanaka, Soichiro Shimizu, Masaru Takasaki, Hideaki Fujita, Naoyuki Kaneko, (unknown), (unknown)	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact